NEWS

BioPhorum’s vision for standardizing the traceability of CGTs

28 April 2023
Advanced Therapy Medicinal Products
Information Technology
David Wallace
Senior Global Change Facilitator

With personalized cell and gene therapies (CGTs), it is critical that the patient receives the therapy that has been made specifically for them. However, traceability for personalized CGTs has not yet reached digital maturity. As a result, there are many approaches but little standardization across CGT license holders, which means that treatment centers and contract organizations must remember many subtle differences in processes and deal with unnecessary complexity.

Some IT providers offer isolated or disconnected solutions to tackle parts of this challenge. However, the proliferation of slightly different approaches creates a cognitive load for those involved, which increases the chances of human error while obstructing a fully integrated approach. Traceability is an issue that impacts the whole process and systems architecture and should not be seen as a single-system solution.

“Most of our healthcare providers are already working with more than five portals: it tends to be one portal per therapy,” said Tour Ala, IT Lead for Cell and Gene Therapy Industrialization for Manufacturing and Supply Chain at Roche. “As more advanced therapies come to market, this is unscalable and unsustainable. As an industry, we desperately need to standardize.”

BioPhorum’s Standardizing traceability of personalized cell and gene therapies will help you meet this challenge by presenting a practical vision and reasoning for standardizing the traceability of CGTs across your value chain.

A user-centric design leads to an architecture that integrates complementary services and a model for connecting data across the systems throughout the supply chain. It considers the current situation and process flows, envisions a series of user stories from the perspective of several key personas, and outlines the benefits of a more holistic approach.

Making connections

Using the standards outlined in this document will help you accelerate the analysis of your business challenges and solution designs, highlight key issues to be resolved, and make it easier for you to align and partner with others working on similar or connected solutions.

This approach will help you standardize the traceability of personalized therapies, automate the enforcement and review of traceability data, and enable robust end-to-end integration. Once traceability is automated and robust, your product release will be faster and anomalies will be resolved more quickly, meeting tight turnaround times and improving patient outcomes.

The paper is a key resource for:

  • Digital leaders, application and interface architects, and designers supporting the supply of personalized CGTs
  • Business leaders who are designing, implementing, and validating chain of identity and chain of custody processes
  • IT solution providers whose systems play a part in the supply of personalized therapies.

“Deployment of systems solutions and integrations is orders of magnitude speedier when there is an industry-standard definition,” said David Gray, Global Solution Architect at Emerson. “It is not just the basis of technical scope and details, but also provides a common vocabulary for conversations among stakeholders.”

The challenge is now for CGT license holders, contract manufacturing organizations, and their IT solution providers to work together to make this a reality. As an industry, we must achieve standardization and a consistent approach that allows us to reach digital maturity, become efficient and flexible, reduce human error, and pave the way for a new generation of advanced personalized therapies to change the lives of people who need them.

For more information, download the paper here and contact David Wallace, Global Change Facilitator, at david.wallace@biophorum.com

Cogs On Dark Blue Background
NEWS
What do your key players need from IT systems in your CGT processes?
Digital arrow, blue
NEWS
Where to start with your biomanufacturing digital transformation
Orchestra Conductor
NEWS
Orchestrating the supply of different cell and gene therapies
PODCAST
BioPhorum introduces – Supply Chain to Patient and data management
NEWS
Shaping the future with our Supply Chain to Patient Strategic Framework

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.

Quality

BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.

Regulatory-CMC

Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.

Sustainability

Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

DOWNLOAD
An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
EXTERNAL-RESOURCE
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
DOWNLOAD
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
DOWNLOAD
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
NEWS
Inaugural BioPhorum Quality face to face – get involved
PODCAST
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
PODCAST
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
DOWNLOAD
A vision for the biopharmaceutical industry’s inbound supply chain
NEWS
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
DOWNLOAD
BioPhorum Technology Roadmapping roadmap vision 2.0

Publications

Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.

Webinars

Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.

Podcasts

BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.

Tools

A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
WEBINAR
Bioreactivity testing in single-use system biomanufacturing